Accuray Inc
NASDAQ:ARAY
Relative Value
The Relative Value of one
ARAY
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.4906 USD,
Accuray Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ARAY Competitors Multiples
Accuray Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Accuray Inc
NASDAQ:ARAY
|
58.3m USD | 0.1 | -1.6 | -83 | -16.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.6B USD | 4.4 | 30 | 17.2 | 23.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.3B USD | 17.4 | 61.4 | 46.6 | 57.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
117.2B USD | 3.3 | 25.4 | 13.9 | 20.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 5.3 | 36.8 | 21.6 | 28.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.2B EUR | 1.9 | 21.4 | 11.8 | 16.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.7B USD | 11.3 | 45.9 | 32.6 | 36.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.1B USD | 2.1 | 26.8 | 10.5 | 17.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.8 | 24.8 | 17.5 | 19.5 |